An update of phase I data from RTOG 0211: A phase I/II clinical study of ZD 1839 (Gefitinib) plus radiation for newly diagnosed glioblastoma (GBM) patients

被引：0
|
作者：
Chakravarti, A
Seiferheld, W
Robins, HI
Guha, A
Brachman, D
Curran, W
Choucair, A
Mehta, M
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Fdn Canc Res, Phoenix, AZ USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] LDS Hosp, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [21] Phase II study of ZD1839 in patients with newly diagnosed grade 4 astrocytoma.
    Uhm, JH
    Ballman, KV
    Giannini, C
    Krauss, C
    Buckner, JC
    James, D
    Scheithauer, BW
    O'Fallon, JR
    Jaeckle, KA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 108S - 108S
  • [22] PHASE I STUDY OF VANDETANIB WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew
    Wong, Eric T.
    Doherty, Lisa
    LaFrankie, Debra
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Lassman, Andrew B.
    Schiff, David
    Batchelor, Tracy
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [23] Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma
    Drappatz, J.
    Norden, A. D.
    Wong, E. T.
    Lassman, A. B.
    Doherty, L.
    LaFrankie, D.
    Gerard, M.
    Phan, P.
    Schiff, D.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma
    Majd, Nazanin
    Yeboa, Debra
    Wang, Shuqi
    Weathers, Shiao-Pei S.
    Yuan, Ying
    Al Anssari, Haider
    Kamiya-Matsuoka, Carlos
    O'Brien, Barbara Jane
    Aaroe, Ashley
    Patel, Chirag B.
    Dagher, Samir
    Wintermark, Max
    Ferguson, Sherise D.
    Puduvalli, Vinay K.
    Liu, Siyuan John
    Raleigh, David R.
    de Groot, John Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM).
    Weathers, Shiao-Pei S.
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca A.
    Liu, Diane D.
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica Elena
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara Jane
    De Groot, John Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy for newly diagnosed glioblastoma
    Ryu, Samuel
    Ye, Xiaobu
    Olson, Jeffrey J.
    Mikkelsen, Tom
    Bangiyev, Lev
    Lesser, Glenn Jay
    Batchelor, Tracy
    Nabors, Louis B.
    Desideri, Serena
    Walbert, Tobias
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] RTOG 0525: Molecular correlates from randomized phase III trial of newly diagnosed glioblastoma (GBM).
    Aldape, K. D.
    Wang, M.
    Sulman, E. P.
    Cahill, D. P.
    Hegi, M.
    Colman, H.
    Jones, G.
    Chakravarti, A.
    Mehta, M. P.
    Andrews, D. W.
    Long, L.
    Diefes, K.
    Heathcock, L.
    Jenkins, R.
    Schultz, C. J.
    Gilbert, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)
    Kleinberg L.
    Ye X.
    Supko J.
    Stevens G.H.J.
    Shu H.-K.
    Mikkelsen T.
    Lieberman F.
    Lesser G.J.
    Lee E.
    Grossman S.A.
    Journal of Neuro-Oncology, 2023, 165 (3) : 499 - 507
  • [29] Prolonged gemcitabine infusion as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): A phase I study.
    Carapella, C. M.
    Mirri, A. M.
    Felici, A.
    Vidiri, A.
    Pace, A.
    Carosi, M. A.
    Occhipinti, E. M.
    Arcangeli, G.
    Cognetti, F.
    Fabi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 78S - 78S
  • [30] Phase I study of gadolinium texaphyrin in newly diagnosed glioblastoma
    Shaw, E. G.
    Grossman, S. A.
    Carson, K. A.
    Fisher, J. D.
    Kleinberg, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345